Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation

View at publisher
Authors: Hongshan Huang
Cited by: 1
References: 27

Fields of Study & Subjects

Neuropeptides and Animal Physiology Neurofibromatosis and Schwannoma Cases Neuroendocrine Tumor Research Advances

Publication details

Journal / source
Life Sciences
Publisher
Elsevier BV
Volume
390
Pages
124250–124250
Publication date
31 January 2026
Language
EN